What is NeuroFlow?
NeuroFlow operates at the intersection of digital health and clinical behavioral science. The company provides a comprehensive platform designed to ensure that patients requiring mental health support are effectively connected to care providers and specialists. By moving beyond simple patient-facing tools, NeuroFlow creates a robust ecosystem that enables remote coordination and the delivery of evidence-based mental health care at scale. This approach addresses the systemic inefficiencies in traditional behavioral health delivery, ensuring that providers can monitor patient progress, identify high-risk individuals, and intervene with precision. Its market position is defined by its ability to integrate seamlessly into existing healthcare workflows, thereby reducing the administrative burden on clinicians while simultaneously improving the quality of care for patients who might otherwise fall through the cracks of the healthcare system.
How much funding has NeuroFlow raised?
NeuroFlow has raised a total of $52.5M across 3 funding rounds:
Series A
$7.5M
Series B
$20M
Other Financing Round
$25M
Series A (2019): $7.5M with participation from AWT Private Investments, Red & Blue Ventures, Dreamit Ventures, Builders VC, and Spring Point Partners
Series B (2021): $20M led by Magellan Health, Inc.
Other Financing Round (2022): $25M supported by SEMCAP Health
Key Investors in NeuroFlow
Builders VC
Builders VC is a venture capital firm focused on modernizing antiquated industries by investing in innovative technologies and solutions that reshape legacy systems.
Red & Blue Ventures
Red & Blue Ventures is an early-stage investment firm that partners with high-growth startups, often leveraging deep ties to academic and research institutions.
Dreamit Ventures
Dreamit Ventures is a growth-focused venture firm that specializes in scaling health-tech and enterprise software companies through strategic operational support.
What's next for NeuroFlow?
With the support of its latest financing, NeuroFlow is well-positioned to accelerate its enterprise-level expansion. The strategic focus will likely shift toward deepening its integration capabilities with major health systems and expanding its suite of clinical decision-support tools. As the demand for remote mental health coordination continues to rise, the company is expected to leverage its capital to enhance its data analytics capabilities, allowing for more personalized patient interventions. Furthermore, the firm is poised to strengthen its partnerships with large-scale healthcare providers, aiming to standardize the delivery of behavioral health services across the continuum of care. By prioritizing interoperability and clinical efficacy, NeuroFlow is set to remain a pivotal player in the digital health landscape, driving the transition toward a more proactive and integrated mental health model.
See full NeuroFlow company page
